IFNA1 and Patent ductus arteriosus: Another limitation is that each PDA cell line-specific CAR T cell resistance has not been fully disclosed, even though we demonstrated that tumor intrinsic IFN signaling and its downstream immune regulators might be an universal resistant mechanism utilized by PDA cells in general.